Share
2 years ago
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
2 years ago
FDA Approves World's First Crispr Gene-Editing Drug for Sickle-Cell Disease
2 years ago
US regulators approve two gene therapies for sickle cell disease
2 years ago
US approves CRISPR gene-editing to treat sickle cell disease
Tags: Sickle-Cell Disease, US, FDA Approves World, regulators, Casgevy, First Crispr Gene-Editing Drug, treatment, gene therapies, CRISPR gene-editing, U.S., sickle cell disease,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines